ArticleMed (New York, N.Y.)2026

Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity.

Miguel A Lopez-Lago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.